Emergent BioSolutions CEO presentation at H.C. Wainwright provides no new financial details

Emergent BioSolutions Inc.

Joseph C. Papa, President and CEO, to present at H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.
Investor presentation furnished as Exhibit 99.1, titled 'Combating Public Health Threats for Communities Around the World'.
No specific financial data, guidance, or operational updates appear in the furnished presentation.
Filing is a Regulation FD disclosure with no other material corporate developments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.